PUBLICATION
The extract of Curcumae Longae Rhizoma suppresses angiogenesis via VEGF-induced PI3K/Akt-eNOS-NO pathway
- Authors
- Guo, G.X., Wu, K.Y., Zhang, X.Y., Lai, F.X., Tsim, K.W., Qin, Q.W., Hu, W.H.
- ID
- ZDB-PUB-230227-36
- Date
- 2023
- Source
- Journal of ethnopharmacology 308: 116299 (Journal)
- Registered Authors
- Keywords
- Angiogenesis, Chinese medicine, Curcumae Longae Rhizoma, VEGF
- MeSH Terms
-
- Zebrafish
- NF-kappa B/metabolism
- Plant Extracts/pharmacology
- Angiogenesis Inhibitors/pharmacology
- Cell Proliferation
- Animals
- Phosphatidylinositol 3-Kinases/metabolism
- Humans
- Proto-Oncogene Proteins c-akt*/metabolism
- Human Umbilical Vein Endothelial Cells
- Cell Movement
- Reactive Oxygen Species/metabolism
- Vascular Endothelial Growth Factor A*/metabolism
- PubMed
- 36842721 Full text @ J. Ethnopharmacol.
Citation
Guo, G.X., Wu, K.Y., Zhang, X.Y., Lai, F.X., Tsim, K.W., Qin, Q.W., Hu, W.H. (2023) The extract of Curcumae Longae Rhizoma suppresses angiogenesis via VEGF-induced PI3K/Akt-eNOS-NO pathway. Journal of ethnopharmacology. 308:116299.
Abstract
Ethnopharmacological relevance Curcumae Longae Rhizoma (CLR) is a safe natural herbal medicine, and which has been widely used for centuries as functional food and health products, but its effects on angiogenesis and related underlying mechanism remain unclear.
Aim of the study The abnormal angiogenesis is closely related with various diseases, and therefore the precise control of angiogenesis is of great importance. The well-known angiogenic factor, vascular endothelial growth factor (VEGF), mediates angiogenesis and induces multiple signalling pathways via binding to VEGF receptor (VEGFR). The attenuation of VEGF-triggered angiogenic-related signalling pathways may relieve various diseases through suppression of angiogenesis. Here, we aimed to elucidate that CLR extract could exert striking anti-angiogenic activities both in vitro and in vivo.
Materials and methods The viability of human umbilical vascular endothelial cell (HUVEC) was examined by LDH and MTT assays. Migrative and invasive ability of the endothelial cells were independently evaluated by wound healing and transwell assays. The activities of CLR extract on in vitro angiogenesis was tested by tube formation assay. In vivo vascularization was determined by using zebrafish embryo model in the present of CLR extract. Western blotting was applied to determine the phosphorylated levels of VEGFR2, PI3K, AKT and eNOS. Besides, the levels of nitric oxide (NO) and reactive oxygen species (ROS) were separately evaluated by Griess assay and 2'7'-dichlorofluorescein diacetate reaction. In addition, the cell migrative ability of cancer cell was estimated by using cultured human colon carcinoma cells (HT-29 cell line), and immunofluorescence assay was applied to evaluate the effect of CLR extract on nuclear translocation of NF-κB p65 subunit in the VEGF-treated HT-29 cultures.
Results CLR extract significantly suppressed a series of VEGF-mediated angiogenic responses, including endothelial cell proliferation, migration, invasion, and tube formation. Moreover, CLR extract reduced in vivo sub-intestinal vessel formation in zebrafish embryo model. Mechanistically, the extract of CLR attenuated the VEGF-triggered signalling, as demonstrated by decreased level of phosphorylated VEGFR2 and subsequently inactivated its downstream regulators, e.g. phospho-PI3K, phospho-AKT and phospho-eNOS. The production of NO and formation of ROS were markedly inhibited in HUVECs. Furthermore, CLR extract suppressed cell migration and NF-κB translocation in cultured HT-29 cells.
Conclusions These preclinical findings demonstrate that the extract of CLR remarkably attenuates angiogenesis and which has great potential as a natural drug candidate with excellent anti-angiogenic activity.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping